Will Class IIb See The Light Of Day? FDA Sends Mixed Messages

It remains unclear how FDA will move forward with its most controversial 510(k) reform proposals, such as creating a separate class IIb category for more complex devices, with mixed messages from the agency on whether the proposals are still on the table.

More from Archive

More from Medtech Insight